Image de couverture de livre

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ruoyuan Qian, Biqing Yang, Xinyi Xu, Bo Lu
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Statistics in Medicine
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
par: Daniel E. Schwartz, et autres
Publié: (2026)

The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101
par: Xi Fang, et autres
Publié: (2025)

RMST for Interval‐Censored Data in Oncology Clinical Trials
par: Xiyuan Gao, et autres
Publié: (2025)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
par: Shu Jiang, et autres
Publié: (2025)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
par: Antonio D'Alessandro, et autres
Publié: (2026)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
par: Jingya Gao, et autres
Publié: (2024)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
par: Yuwei Cheng, et autres
Publié: (2026)

Bayesian Random‐Effects Meta‐Analysis of Aggregate Data on Clinical Events
par: Christian Röver, et autres
Publié: (2026)

Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
par: Junichi Asano, et autres
Publié: (2026)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
par: Xiaotian Chen, et autres
Publié: (2025)

MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights
par: Yeonhee Park, et autres
Publié: (2025)

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
par: Godwin Yung, et autres
Publié: (2025)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
par: Yunyi Liu, et autres
Publié: (2026)

Futility Monitoring in Clinical Trials
par: Ana M. Ortega‐Villa, et autres
Publié: (2025)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
par: Hyejung Jung, et autres
Publié: (2026)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
par: Elizabeth L. Turner, et autres
Publié: (2026)

Powerful Test of Heterogeneity in Two‐Sample Summary‐Data Mendelian Randomization
par: Kai Wang, et autres
Publié: (2024)

Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout
par: Analissa Avila, et autres
Publié: (2025)

A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting
par: Niki Z. Petrakos, et autres
Publié: (2025)

An Augmented Likelihood Approach Incorporating Error‐Prone Auxiliary Data Into a Survival Analysis
par: Noorie Hyun, et autres
Publié: (2025)

Model‐Robust Standardization in Cluster‐Randomized Trials
par: Fan Li, et autres
Publié: (2025)

Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling
par: Alessandro Gasparini, et autres
Publié: (2025)

Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
par: M. C. Donohue, et autres
Publié: (2025)

Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data
par: Guoqiao Wang, et autres
Publié: (2024)

Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
par: Jiaqi Tong, et autres
Publié: (2025)

Correction to “Model‐Robust Standardization in Cluster‐Randomized Trials”
Publié: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
par: Hao Wang, et autres
Publié: (2026)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
par: Zhe Chen, et autres
Publié: (2026)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
par: Ethan Ashby, et autres
Publié: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
par: Liwen Wu, et autres
Publié: (2025)

Testing for Similarity of Dose Response in Multiregional Clinical Trials
par: Holger Dette, et autres
Publié: (2025)

An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
par: Erik W. van Zwet, et autres
Publié: (2026)

Patient‐Centric Pragmatic Clinical Trials: Opening the DOOR
par: Scott R. Evans, et autres
Publié: (2026)

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin
par: Guangyong Zou, et autres
Publié: (2024)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
par: Guoqiao Wang, et autres
Publié: (2025)

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials
par: Marco Ratta, et autres
Publié: (2026)

Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance
par: Wenli Liu, et autres
Publié: (2025)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
par: Maria Vittoria Chiaruttini, et autres
Publié: (2026)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
par: Alessandra Serra, et autres
Publié: (2025)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
par: Gi‐Ming Wang, et autres
Publié: (2026)